Abstract Details

Title Hemodynamic properties of SAGE-547 in patients with super-refractory status epilepticus: results from a phase 1/2 clinical trial

Topic Epilepsy/Clinical Neurophysiology (EEG)

Presentation(s) P6 - (-)

Poster/Presentation
Number 234

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Helen Colquhoun PRESENTER	Helen Colquhoun has received personal compensation for serving as an employee of Sage Therapeutics. Helen Colquhoun has stock in Sage Therapeutics. Helen Colquhoun has received intellectual property interests from a discovery or technology relating to health care.
Shane Raines	Shane Raines has received personal compensation for serving as an employee of 2b Analytics, LLC.
Stephen Kanes	No disclosure on file

��ɫ��